Edgestream Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.78M | Sell |
218,392
-22,895
| -9% | -$396K | 0.11% | 368 |
|
|
2025
Q1 | $5.28M | Buy |
241,287
+131,404
| +120% | +$2.87M | 0.18% | 215 |
|
|
2024
Q4 | $3.51M | Buy |
109,883
+10,482
| +11% | +$334K | 0.15% | 264 |
|
|
2024
Q3 | $2.87M | Buy |
99,401
+44,829
| +82% | +$1.29M | 0.13% | 295 |
|
|
2024
Q2 | $2.09M | Buy |
54,572
+38,541
| +240% | +$1.48M | 0.1% | 318 |
|
|
2024
Q1 | $942K | Buy |
+16,031
| New | +$942K | 0.05% | 514 |
|